{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:01:32Z","timestamp":1780354892354,"version":"3.54.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.3816\/clm.2003.n.010","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:05Z","timestamp":1221095405000},"page":"22-29","source":"Crossref","is-referenced-by-count":44,"title":["Primary Ocular Lymphoma: Clinical Features, Diagnosis, and Treatment"],"prefix":"10.3816","volume":"4","author":[{"given":"Ad\u00edlia","family":"Hormigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2003.n.010_bib1","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0161-6420(93)31469-7","article-title":"Intraocular lymphoma: clinical and histopathologic diagnosis","volume":"100","author":"Whitcup","year":"1993","journal-title":"Ophthalmology"},{"key":"10.3816\/CLM.2003.n.010_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3171\/jns.1988.68.6.0835","article-title":"Primary central nervous system lymphoma","volume":"68","author":"Hochberg","year":"1988","journal-title":"J Neurosurg"},{"key":"10.3816\/CLM.2003.n.010_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1006290032052","article-title":"Epidemiology of primary CNS lymphoma","volume":"43","author":"Schabet","year":"1999","journal-title":"J Neurooncol"},{"key":"10.3816\/CLM.2003.n.010_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00001622-200105000-00005","article-title":"Brain and other central nervous system tumors: rates, trends and epidemiology","volume":"13","author":"Gurney","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib5","first-page":"14","article-title":"Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States 1990-1994","volume":"1","author":"Surawicz","year":"1999","journal-title":"Neurooncol"},{"key":"10.3816\/CLM.2003.n.010_bib6","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2409::AID-CNCR17>3.0.CO;2-V","article-title":"Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?","volume":"79","author":"Corn","year":"1997","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib7","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M","article-title":"Increasing incidence of primary brain lymphoma in the US","volume":"62","author":"Eby","year":"1988","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0161-6420(00)00499-1","article-title":"Uveitis masquerade syndromes","volume":"108","author":"Rothova","year":"2001","journal-title":"Ophthalmology"},{"key":"10.3816\/CLM.2003.n.010_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0039-6257(01)00305-8","article-title":"Neoplastic masquerade syndromes","volume":"47","author":"Read","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib10","first-page":"224","article-title":"Intraocular reticulum-cell sarcoma: clinico-pathologic study of four cases and review of the literature","volume":"19","author":"Barr","year":"1975","journal-title":"Surv Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3171\/jns.1984.61.2.0369","article-title":"Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma). Report of three cases","volume":"61","author":"Rockwood","year":"1984","journal-title":"J Neurosurg"},{"key":"10.3816\/CLM.2003.n.010_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1097-0142(19830901)52:5<878::AID-CNCR2820520523>3.0.CO;2-D","article-title":"Intraocular lymphomas: natural history based on clinicopathologic study of eight cases and reviews of the literature","volume":"52","author":"Qualman","year":"1983","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0161-6420(88)33145-3","article-title":"Primary intraocular lymphoma (ocular reticulum cell sarcoma). Diagnosis and management","volume":"95","author":"Char","year":"1988","journal-title":"Ophthalmology"},{"key":"10.3816\/CLM.2003.n.010_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1076\/ocii.8.4.243.6463","article-title":"Ocular and central nervous system lymphoma: clinical features and diagnosis","volume":"8","author":"Cassoux","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.3816\/CLM.2003.n.010_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bjo.73.5.342","article-title":"Ten-year experience with primary ocular \u2018reticulum cell sarcoma\u2019 (large cell non-Hodgkin's lymphoma)","volume":"73","author":"Siegel","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0025-6196(12)62276-9","article-title":"Intravitreal large-cell lymphoma","volume":"68","author":"Buettner","year":"1993","journal-title":"Mayo Clin Proc"},{"key":"10.3816\/CLM.2003.n.010_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.40.1.80","article-title":"Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy","volume":"40","author":"DeAngelis","year":"1990","journal-title":"Neurology"},{"key":"10.3816\/CLM.2003.n.010_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/1097-0142(19930801)72:3<843::AID-CNCR2820720333>3.0.CO;2-#","article-title":"The clinical spectrum of ocular lymphoma","volume":"72","author":"Peterson","year":"1993","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM197301252880403","article-title":"Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative disorders","volume":"288","author":"Piessens","year":"1973","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.010_bib20","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1992.01080220117032","article-title":"Intraocular lymphoma: immunopathologic analysis of vitreous biopsy specimen","volume":"110","author":"Wilson","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib21","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0161-6420(02)01132-6","article-title":"Human T-cell lymphotropic virus Type-1 associated T-cell leukemia\/lymphoma masquerading as necrotizing retinal vasculitis","volume":"109","author":"Levy-Clarke","year":"2002","journal-title":"Ophthalmology"},{"key":"10.3816\/CLM.2003.n.010_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/107327489800500403","article-title":"Intraocular lymphoma","volume":"5","author":"Bardenstein","year":"1998","journal-title":"Cancer Control"},{"key":"10.3816\/CLM.2003.n.010_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00004397-199703740-00009","article-title":"Primary intraocular lymphoma","volume":"37","author":"Merchant","year":"1997","journal-title":"Int Ophthalmol Clin"},{"key":"10.3816\/CLM.2003.n.010_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00006982-200202000-00007","article-title":"Fluorescein angiographic findings in primary intraocular lymphoma","volume":"22","author":"Velez","year":"2002","journal-title":"Retina"},{"key":"10.3816\/CLM.2003.n.010_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0039-6257(00)00118-1","article-title":"Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature","volume":"44","author":"Velez","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib26","series-title":"Immunology of Ocular Tumors","first-page":"15","article-title":"Ocular immune privilege and tumors","author":"Streilein","year":"2002"},{"key":"10.3816\/CLM.2003.n.010_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0039-6257(01)00217-X","article-title":"Variations in the presentation of primary intraocular lymphoma: case reports and a review","volume":"45","author":"Gill","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1006242116122","article-title":"Classification, pathogenesis and molecular pathology of primary CNS lymphomas","volume":"43","author":"Paulus","year":"1999","journal-title":"J Neurooncol"},{"key":"10.3816\/CLM.2003.n.010_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1566524013363915","article-title":"Molecular analysis of primary central nervous system and primary intraocular lymphomas","volume":"1","author":"Tuaillon","year":"2001","journal-title":"Curr Mol Med"},{"key":"10.3816\/CLM.2003.n.010_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/WNL.50.2.335","article-title":"Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS","volume":"50","author":"Corboy","year":"1998","journal-title":"Neurology"},{"key":"10.3816\/CLM.2003.n.010_bib31","series-title":"Immunology of Ocular Tumors","article-title":"Immunopathology and molecular biology of primary intraocular lymphoma","author":"Chan","year":"2002"},{"key":"10.3816\/CLM.2003.n.010_bib32","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood.V93.8.2749","article-title":"Detection of human herpesvirus-8 and Epstein-Barr virus DNA in primary intraocular lymphomas","volume":"93","author":"Chan","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.010_bib33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/modpathol.3880424","article-title":"Detection of Toxoplasma Gondii DNA in primary intraocular B-cell lymphoma","volume":"14","author":"Shen","year":"2001","journal-title":"Mod Pathol"},{"key":"10.3816\/CLM.2003.n.010_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bjo.82.3.245","article-title":"Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis","volume":"82","author":"Ongkosuwito","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00006982-199901000-00007","article-title":"Primary ocular Epstein-Barr virus associated non-Hodgkin's lymphoma in a patient with AIDS. A clinicopathologic report","volume":"19","author":"Mittra","year":"1999","journal-title":"Retina"},{"key":"10.3816\/CLM.2003.n.010_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00006982-199703000-00006","article-title":"Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement","volume":"17","author":"Ursea","year":"1997","journal-title":"Retina"},{"key":"10.3816\/CLM.2003.n.010_bib37","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0161-6420(99)90341-X","article-title":"Intraocular-central nervous sys- tem lymphoma. Clinical features, diagnosis and outcome","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthamology"},{"key":"10.3816\/CLM.2003.n.010_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00001622-200105000-00001","article-title":"Ocular manifestations of central nervous system lymphoma","volume":"13","author":"Buggage","year":"2001","journal-title":"Cur Opin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00006982-199807000-00002","article-title":"Two types of initial ocular manifestations in intraocular-central nervous system lymphoma","volume":"18","author":"Matsuo","year":"1998","journal-title":"Retina"},{"key":"10.3816\/CLM.2003.n.010_bib40","first-page":"617","article-title":"Primary intraocular lymphoma seen with transient white fundus lesions simulating the multiple evanescent white dot syndrome","volume":"119","author":"Shah","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3171\/jns.1979.50.5.0660","article-title":"Uveitis and cerebral reticulumcell sarcoma (large-cell lymphoma)","volume":"50","author":"Rosenbaum","year":"1979","journal-title":"J Neurosurg"},{"key":"10.3816\/CLM.2003.n.010_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10428199609054837","article-title":"A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases","volume":"23","author":"Soussain","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2003.n.010_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1006254518848","article-title":"Glucocorticoid treatment of primary CNS lymphoma","volume":"43","author":"Weller","year":"1999","journal-title":"J Neurooncol"},{"key":"10.3816\/CLM.2003.n.010_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00006982-200106000-00023","article-title":"Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion","volume":"21","author":"Levy-Clarke","year":"2001","journal-title":"Retina"},{"key":"10.3816\/CLM.2003.n.010_bib45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9394(14)70828-1","article-title":"Diagnosis of intraocular lymphoma by flow cytometry","volume":"124","author":"Davis","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archopht.1997.01100160327010","article-title":"Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma","volume":"115","author":"Whitcup","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib47","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0161-6420(99)90528-6","article-title":"Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthalmology"},{"key":"10.3816\/CLM.2003.n.010_bib48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archopht.117.6.761","article-title":"Use of polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma","volume":"117","author":"White","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib49","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archopht.117.9.1239","article-title":"Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogenous IgH gene rearrangement","volume":"117","author":"Buggage","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1006250317940","article-title":"Primary CNS lymphoma: findings outside the brain","volume":"43","author":"Herrlinger","year":"1999","journal-title":"J Neurooncol"},{"key":"10.3816\/CLM.2003.n.010_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1097-0142(196303)16:3<289::AID-CNCR2820160304>3.0.CO;2-Z","article-title":"Neoplasms of the reticuloendothelial system of the brain","volume":"16","author":"Burnstein","year":"1963","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib52","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-P","article-title":"Primary malignant lymphomas of the central nervous system","volume":"34","author":"Henry","year":"1974","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib53","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/1097-0142(19831201)52:11<1993::AID-CNCR2820521104>3.0.CO;2-C","article-title":"Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases","volume":"52","author":"Mendenhall","year":"1983","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib54","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1097-0142(19890301)63:5<939::AID-CNCR2820630526>3.0.CO;2-V","article-title":"Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma","volume":"63","author":"Pollack","year":"1989","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib55","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","article-title":"Treatment for primary CNS lymphoma: the next step","volume":"18","author":"Abrey","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(00)00385-3","article-title":"Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment","volume":"181","author":"Schlegel","year":"2000","journal-title":"J Neurol Sciences"},{"key":"10.3816\/CLM.2003.n.010_bib57","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.1999.17.4.1326c","article-title":"Intraocular methotrexate level after highdose intravenous infusion","volume":"17","author":"Henson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib58","first-page":"711","article-title":"High-dose methotrexate for intraocular lymphoma","volume":"9","author":"Batchelor","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2003.n.010_bib59","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/1097-0142(19860401)57:7<1273::AID-CNCR2820570702>3.0.CO;2-C","article-title":"Treatment of intraocular lymphoma with high-dose Ara-C","volume":"57","author":"Baumann","year":"1986","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","article-title":"Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315","volume":"23","author":"Nelson","year":"1992","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.3816\/CLM.2003.n.010_bib61","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.WNL.0000034256.20173.EA","article-title":"Primary CNS lymphoma. A wholebrain disease?","volume":"59","author":"Lai","year":"2002","journal-title":"Neurology"},{"key":"10.3816\/CLM.2003.n.010_bib62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0360-3016(90)90398-4","article-title":"Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone","volume":"18","author":"Brada","year":"1990","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.3816\/CLM.2003.n.010_bib63","first-page":"162","article-title":"Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study","volume":"42","author":"Shibamato","year":"1999","journal-title":"J Neurooncol"},{"key":"10.3816\/CLM.2003.n.010_bib64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0360-3016(98)00450-7","article-title":"Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? a final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52","volume":"43","author":"O'Neill","year":"1999","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.3816\/CLM.2003.n.010_bib65","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1996.14.2.556","article-title":"Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group protocol 88-06","volume":"14","author":"Schultz","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib66","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","article-title":"Combined modality therapy for primary CNS lymphoma","volume":"10","author":"DeAngelis","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib67","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3171\/jns.1994.81.2.0188","article-title":"Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome","volume":"81","author":"Glass","year":"1994","journal-title":"J Neurosurg"},{"key":"10.3816\/CLM.2003.n.010_bib68","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1998.16.3.859","article-title":"Long-term survival in primary CNS lymphoma","volume":"16","author":"Abrey","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.46.2.435","article-title":"Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients","volume":"46","author":"Freilich","year":"1996","journal-title":"Neurology"},{"key":"10.3816\/CLM.2003.n.010_bib70","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1998.16.9.3000","article-title":"phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma","volume":"16","author":"Sandor","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib71","first-page":"75a","article-title":"Primary central nervous system lymphoma: the Massachusetts General Hospital","volume":"21","author":"Lawler","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00006123-200001000-00010","article-title":"Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma","volume":"46","author":"McAllister","year":"2000","journal-title":"Neurosurgery"},{"key":"10.3816\/CLM.2003.n.010_bib73","first-page":"53a","article-title":"A phase II study of intensive methotrexate and cytarabine followed by high dose beam chemotherapy with autologous stem cell transplantation in patients with newly diagnosed primary central nervous system lymphoma","volume":"20","author":"Abrey","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib74","first-page":"166a","article-title":"Activity of Rituximab in primary central nervous system lymphoma","volume":"19","author":"Raizer","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib75","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/annonc\/mdf080","article-title":"Relevance of intraocular involvement in the management of primary central nervous system lymphoma","volume":"13","author":"Ferreri","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib76","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000055310","article-title":"Combined treatment with highdose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients","volume":"60","author":"Ferreri","year":"2001","journal-title":"Oncology"},{"key":"10.3816\/CLM.2003.n.010_bib77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1016077907952","article-title":"Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?","volume":"58","author":"Khan","year":"2002","journal-title":"J Neurooncol"},{"key":"10.3816\/CLM.2003.n.010_bib78","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00000421-198804000-00008","article-title":"Intraocular lymphoma: report of three cases and review of literature","volume":"11","author":"Trudeau","year":"1988","journal-title":"Am J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib79","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/1097-0142(19800215)45:4<688::AID-CNCR2820450412>3.0.CO;2-F","article-title":"The role of radiation therapy in the management of ocular reticulum cell sarcoma","volume":"45","author":"Margolis","year":"1980","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00006982-199515020-00006","article-title":"Combination treatment of intraocular lymphoma","volume":"15","author":"Valluri","year":"1995","journal-title":"Retina"},{"key":"10.3816\/CLM.2003.n.010_bib81","first-page":"401","article-title":"Intraocular reticulum cell sarcoma: its dramatic response to systemic chemotherapy and its angiogenic potential","volume":"9","author":"Sullivan","year":"1977","journal-title":"Ann Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib82","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0002-9394(14)70444-1","article-title":"Intraocular levels of methotrexate after intravenous administration","volume":"121","author":"Smet","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib83","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1097-0142(19890515)63:10<1918::AID-CNCR2820631008>3.0.CO;2-D","article-title":"Chemotherapy in the management of intraocular lymphoma","volume":"63","author":"Strauchen","year":"1989","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.010_bib84","first-page":"75a","article-title":"Treatment of ocular lymphoma","volume":"21","author":"Hormigo","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.010_bib85","unstructured":"Hormigo A, DeAngelis LM. Treatment of primary central nervous system lymphoma in immunocompetent patients. In: Batchelor T, ed. Lymphoma of the Nervous System. Boston, Mass: Elsevier Science. In press."},{"key":"10.3816\/CLM.2003.n.010_bib86","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archopht.1997.01100160322009","article-title":"Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma","volume":"115","author":"Fishburne","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib87","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.83.4.448","article-title":"Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma","volume":"83","author":"Smet","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.3816\/CLM.2003.n.010_bib88","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3928\/1542-8877-20020701-16","article-title":"Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma","volume":"33","author":"Velez","year":"2002","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.3816\/CLM.2003.n.010_bib89","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0161-6420(02)01125-9","article-title":"Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement","volume":"109","author":"Smith","year":"2002","journal-title":"Ophthalmology"},{"key":"10.3816\/CLM.2003.n.010_bib90","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archopht.119.10.1518","article-title":"Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma","volume":"119","author":"Velez","year":"2001","journal-title":"Arch Ophthalmol"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511700045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511700045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:48:10Z","timestamp":1631778490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511700045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S1526965511700045"],"URL":"https:\/\/doi.org\/10.3816\/clm.2003.n.010","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}